SCHEMBL25946261

SCHEMBL25946261

Nc1ncnc2c1ncn2C1OC(CSc2ccc3ccccc3n2)[C@@H](O)[C@H]1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNMT Q14749 2/20 0.66
AHCY P23526 7/20 0.66
NADK O95544 1/20 0.66
DOT1L Q8TEK3 3/20 0.60
DNMT3B Q9UBC3 2/20 0.60
PNMT P11086 1/20 0.60
DNMT1 P26358 1/20 0.60
DPP4 P27487 1/20 0.59
MEN1 O00255 1/20 0.59
SLC28A1 O00337 1/20 0.59
MAP3K7 O43318 1/20 0.59
SLC28A2 O43868 1/20 0.59
GAPDH P04406 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
MAPK1 P28482 1/20 0.59
ADORA2A P29274 1/20 0.59
ADORA2B P29275 1/20 0.59
ADORA1 P30542 1/20 0.59
STAT6 P42226 1/20 0.59
PI4KA P42356 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18572517 1.00 GNMT (0.66) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL22683278 1.00 GNMT (0.66) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL6905922 1.00 GNMT (0.66) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL22683279 0.85 GNMT (0.76) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL18572516 0.85 GNMT (0.76) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL18572550 0.85 GNMT (0.76) GNMTAHCYNADKDOT1LDNMT3B
SCHEMBL6893100 0.85 AHCY (0.70) GNMTAHCYNADKDOT1LDNMT3B
Adenosine SCHEMBL1128079 0.83 ADORA3 (0.74) GNMTAHCYNADKDOT1LDPP4
SCHEMBL6908163 0.81 AHCY (0.76) AHCYNADKDOT1LDNMT3BPNMT
SCHEMBL6908804 0.80 AHCY (0.69) GNMTAHCYNADKDOT1LDNMT3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219496-A1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed